References
- Adikwu MU. (2009). Biopolymers in drug delivery: recent advances and challenges. Bentham Science Publishers, 1–198. (DOI: 10.2174/97816080507891090101)
- Apostolopoulos V, Barnes N, Pietersz GA, McKenzie IF (2000). Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine 18:3174–84
- Colditz GA, Brewer TF, Berkey CS, et al. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698–702
- Collnot E-M, Ali H, Lehr C-M. (2012). Nano-and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release 161:235–46
- Conner SD, Schmid SL. (2003). Regulated portals of entry into the cell. Nature 422:37–44
- Cummings J, Branch W, Jenkins D, et al. (1978). Colonic response to dietary fibre from carrot, cabbage, apple, bran, and guar gum. Lancet 311:5–9
- Dou J, Chen JS, Wang J, et al. (2005). Novel constructs of tuberculosis gene vaccine and its immune effect on mice. Cell Mol Immunol 2:57–62
- Engering AJ, Cella M, Fluitsma D, et al. (1997a). The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 27:2417–25
- Engering AJ, Cella M, Fluitsma DM, et al. (1997b). Mannose receptor mediated antigen uptake and presentation in human dendritic cells. Adv Exp Med Biol 417:183–7
- Frey A, Giannasca KT, Weltzin R, et al. (1996). Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 184:1045–59
- Frey A, Neutra MR. (1997). Targeting of mucosal vaccines to Peyer's patch M cells. Behring Institute Mitteilungen 98:376–89
- Garg T, Singh O, Arora S, Murthy R. (2012). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Therap Drug Carrier Systems 29:1–63
- Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Therap Drug Carrier Systems 30:369–409
- Gebert A, Rothkotter HJ, Pabst R. (1996). M cells in Peyer's patches of the intestine. Intern Rev Cytol 167:91–159
- Guo M, Gong S, Maric S, et al. (2000). A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Human Immunol 61:729–38
- Launois P, DeLeys R, Niang MN, et al. (1994). T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 62:3679–87
- Lelouard H, Fallet M, de Bovis B, et al. (2012). Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores. Gastroenterology 142:592–601
- Li X, Kong X, Shi S, et al. (2008). Preparation of alginate coated chitosan microparticles for vaccine delivery. BMC Biotechnol 8:89
- Lizee G, Basha G, Jefferies WA. (2005). Tails of wonder: endocytic-sorting motifs key for exogenous antigen presentation. Trends Immunol 26:141–9
- Malik B, Goyal AK, Markandeywar T, et al. (2012). Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target 20:76–84
- Mogues T, Goodrich ME, Ryan L, et al. (2001). The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193:271–80
- Prabaharan M. (2011). Prospective of guar gum and its derivatives as controlled drug delivery systems. Int J Biol Macromol 49:117–24
- Prasad YV, Krishnaiah YS, Satyanarayana S. (1998). In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J Control Release 51:281–7
- Regnault A, Lankar D, Lacabanne V, et al. (1999). Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189:371–80
- Sallusto F, Cella M, Danieli C, Lanzavecchia A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389–400
- Tascon RE, Stavropoulos E, Lukacs KV, Colston MJ. (1998). Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun 66:830–4
- Van Der Lubben I, Konings F, Borchard G, et al. (2001b). In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target 9:39–47
- Van der Lubben I, Verhoef J, Van Aelst A, et al. (2001a). Chitosan microparticles for oral vaccination:: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 22:687–94